Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jacqui T. Nimmo"'
Autor:
Jacqui T. Nimmo, Ajay Verma, Jean-Cosme Dodart, Chang Yi Wang, Jimmy Savistchenko, Ronald Melki, Roxana O. Carare, James A. R. Nicoll
Publikováno v:
Alzheimer’s Research & Therapy, Vol 15, Iss 1, Pp 1-3 (2023)
Externí odkaz:
https://doaj.org/article/447ea994616d4ac8b55d79623083c238
Autor:
Jacqui T. Nimmo, Ajay Verma, Jean-Cosme Dodart, Chang Yi Wang, Jimmy Savistchenko, Ronald Melki, Roxana O. Carare, James A. R. Nicoll
Publikováno v:
Alzheimer’s Research & Therapy, Vol 12, Iss 1, Pp 1-16 (2020)
Abstract Background Alpha-synuclein (α-Syn) aggregation is the primary characteristic of synucleinopathies including Parkinson’s disease (PD), dementia with Lewy bodies (DLB) and multiple system atrophy (MSA). Immunotherapy targeting α-Syn has sh
Externí odkaz:
https://doaj.org/article/5506ca7a32bf4a21a4d9aa150641dafa
Autor:
James A. R. Nicoll, Harry Smith, Jean-Cosme Dodart, Ajay Verma, Jacqui T. Nimmo, Zhi Liu, Chang Yi Wang, Jessica L. Teeling, Roxana O. Carare, Feng Lin
Publikováno v:
Acta Neuropathologica
Alpha synuclein has a key role in the pathogenesis of Parkinson’s disease (PD), Dementia with Lewy Bodies (LBD) and Multiple System Atrophy (MSA). Immunotherapies aiming at neutralising toxic αSyn species are being investigated in the clinic as po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0117d87c123630e1d6bfd8dfea0ec14
http://europepmc.org/articles/PMC8732825
http://europepmc.org/articles/PMC8732825
Autor:
James A. R. Nicoll, Louise Kelly, Jacqui T. Nimmo, Jean-Cosme Dodart, Roxana O. Carare, Ajay Verma
Publikováno v:
Frontiers in Neuroscience
Frontiers in Neuroscience, Vol 15 (2021)
Frontiers in Neuroscience, Vol 15 (2021)
Alzheimer’s disease and Lewy body diseases are the most common causes of neurodegeneration and dementia. Amyloid-beta (Aβ) and alpha-synuclein (αSyn) are two key proteins involved in the pathogenesis of these neurodegenerative diseases. Immunothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be31a599dbecf0b102ae66f7061dce97
http://europepmc.org/articles/PMC8441015
http://europepmc.org/articles/PMC8441015
Autor:
Ronald Melki, Jimmy Savistchenko, Jean-Cosme Dodart, Roxana O. Carare, Chang Yi Wang, James A. R. Nicoll, Jacqui T. Nimmo, Ajay Verma
Publikováno v:
Alzheimer's Research & Therapy
Alzheimer's Research & Therapy, 2020, 12 (1), ⟨10.1186/s13195-020-00727-x⟩
Alzheimer’s Research & Therapy, Vol 12, Iss 1, Pp 1-16 (2020)
Alzheimer's Research and Therapy
Alzheimer's Research and Therapy, 2020, 12 (1), ⟨10.1186/s13195-020-00727-x⟩
Alzheimer's Research & Therapy, 2020, 12 (1), ⟨10.1186/s13195-020-00727-x⟩
Alzheimer’s Research & Therapy, Vol 12, Iss 1, Pp 1-16 (2020)
Alzheimer's Research and Therapy
Alzheimer's Research and Therapy, 2020, 12 (1), ⟨10.1186/s13195-020-00727-x⟩
Background Alpha-synuclein (α-Syn) aggregation is the primary characteristic of synucleinopathies including Parkinson’s disease (PD), dementia with Lewy bodies (DLB) and multiple system atrophy (MSA). Immunotherapy targeting α-Syn has shown promi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6da6ecb5f427c02ad6fdd22ee21fc07c
https://doi.org/10.1186/s13195-020-00727-x
https://doi.org/10.1186/s13195-020-00727-x